University of Hertfordshire

Standard

The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries. / Howard, Natasha; Bell, Sadie; Walls, Helen; Blanchard, Laurence; Brenzel, Logan; Jit, Mark; Mounier-Jack, Sandra.

In: Human Vaccines & Immunotherapeutics, Vol. 14, No. 6, 26.03.2018, p. 1539.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Howard, Natasha ; Bell, Sadie ; Walls, Helen ; Blanchard, Laurence ; Brenzel, Logan ; Jit, Mark ; Mounier-Jack, Sandra. / The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries. In: Human Vaccines & Immunotherapeutics. 2018 ; Vol. 14, No. 6. pp. 1539.

Bibtex

@article{c2bd85803b5b4cf3a62b3bf2cd1395fc,
title = "The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries",
abstract = "National Immunisation Technical Advisory Groups (NITAGs) provide independent guidance to health ministries to support evidence-based and nationally relevant immunisation decisions. We examined NITAGs' value, sustainability, and need for support in low and middle-income countries, drawing from a mixed-methods study including 130 global and national-level key informant interviews. NITAGs were particularly valued for providing independent and nationally owned evidence-based decision-making (EBDM), but needed to be integrated within national processes to effectively balance independence and influence. Participants agreed that most NITAGs, being relatively new, would need developmental and strengthening support for at least a decade. While national governments could support NITAG functioning, external support is likely needed for requisite capacity building. This might come from Gavi mechanisms and WHO, but would require alignment among stakeholders to be effective.",
keywords = "vaccine, Decision Making, international",
author = "Natasha Howard and Sadie Bell and Helen Walls and Laurence Blanchard and Logan Brenzel and Mark Jit and Sandra Mounier-Jack",
year = "2018",
month = mar,
day = "26",
doi = "10.1080/21645515.2018.1444321",
language = "English",
volume = "14",
pages = "1539",
journal = "Human Vaccines & Immunotherapeutics",
issn = "2164-554X",
publisher = "Taylor & Francis",
number = "6",

}

RIS

TY - JOUR

T1 - The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries

AU - Howard, Natasha

AU - Bell, Sadie

AU - Walls, Helen

AU - Blanchard, Laurence

AU - Brenzel, Logan

AU - Jit, Mark

AU - Mounier-Jack, Sandra

PY - 2018/3/26

Y1 - 2018/3/26

N2 - National Immunisation Technical Advisory Groups (NITAGs) provide independent guidance to health ministries to support evidence-based and nationally relevant immunisation decisions. We examined NITAGs' value, sustainability, and need for support in low and middle-income countries, drawing from a mixed-methods study including 130 global and national-level key informant interviews. NITAGs were particularly valued for providing independent and nationally owned evidence-based decision-making (EBDM), but needed to be integrated within national processes to effectively balance independence and influence. Participants agreed that most NITAGs, being relatively new, would need developmental and strengthening support for at least a decade. While national governments could support NITAG functioning, external support is likely needed for requisite capacity building. This might come from Gavi mechanisms and WHO, but would require alignment among stakeholders to be effective.

AB - National Immunisation Technical Advisory Groups (NITAGs) provide independent guidance to health ministries to support evidence-based and nationally relevant immunisation decisions. We examined NITAGs' value, sustainability, and need for support in low and middle-income countries, drawing from a mixed-methods study including 130 global and national-level key informant interviews. NITAGs were particularly valued for providing independent and nationally owned evidence-based decision-making (EBDM), but needed to be integrated within national processes to effectively balance independence and influence. Participants agreed that most NITAGs, being relatively new, would need developmental and strengthening support for at least a decade. While national governments could support NITAG functioning, external support is likely needed for requisite capacity building. This might come from Gavi mechanisms and WHO, but would require alignment among stakeholders to be effective.

KW - vaccine

KW - Decision Making

KW - international

U2 - 10.1080/21645515.2018.1444321

DO - 10.1080/21645515.2018.1444321

M3 - Article

VL - 14

SP - 1539

JO - Human Vaccines & Immunotherapeutics

JF - Human Vaccines & Immunotherapeutics

SN - 2164-554X

IS - 6

ER -